The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1

MicroRNAs (miRNAs) are small regulatory RNAs that participate in posttranscriptional gene regulation in a sequence-specific manner. However, little is understood about the role(s) of miRNAs in Alzheimer's disease (AD). We used miRNA expression microarrays on RNA extracted from human brain tissue from the University of Kentucky Alzheimer's Disease Center Brain Bank with near-optimal clinicopathological correlation. Cases were separated into four groups: elderly nondemented with negligible AD-type pathology, nondemented with incipient AD pathology, mild cognitive impairment (MCI) with moderate AD pathology, and AD. Among the AD-related miRNA expression changes, miR-107 was exceptional because miR-107 levels decreased significantly even in patients with the earliest stages of pathology. In situ hybridization with cross-comparison to neuropathology demonstrated that particular cerebral cortical laminas involved by AD pathology exhibit diminished neuronal miR-107 expression. Computational analysis predicted that the 3′-untranslated region (UTR) of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) mRNA is targeted multiply by miR-107. From the same RNA material analyzed on miRNA microarrays, mRNA expression profiling was performed using Affymetrix Exon Array microarrays on nondemented, MCI, and AD patients. BACE1 mRNA levels tended to increase as miR-107 levels decreased in the progression of AD. Cell culture reporter assays performed with a subset of the predicted miR-107 binding sites indicate the presence of at least one physiological miR-107 miRNA recognition sequence in the 3′-UTR of BACE1 mRNA. Together, the coordinated application of miRNA profiling, Affymetrix microarrays, new bioinformatics predictions, in situ hybridization, and biochemical validation indicate that miR-107 may be involved in accelerated disease progression through regulation of BACE1.

[1]  L. Goff,et al.  Rational Probe Optimization and Enhanced Detection Strategy for MicroRNAs Using Microarrays , 2005, RNA biology.

[2]  F. Checler,et al.  Post-transcriptional Contribution of a cAMP-dependent Pathway to the Formation of α- and β/γ-Secretases-Derived Products of βAPP Maturation in Human Cells Expressing Wild-type and Swedish Mutated βAPP , 1998, Molecular medicine.

[3]  R. Tanzi,et al.  Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. , 2007, Neuron.

[4]  S. Hébert,et al.  miRNAs in Neurodegeneration , 2007, Science.

[5]  Stefano Volinia,et al.  MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Artemis G Hatzigeorgiou,et al.  miRNP:mRNA association in polyribosomes in a human neuronal cell line. , 2004, RNA.

[7]  Xiaoqing Tang,et al.  A simple array platform for microRNA analysis and its application in mouse tissues. , 2007, RNA.

[8]  G. Maira,et al.  Extensive modulation of a set of microRNAs in primary glioblastoma. , 2005, Biochemical and biophysical research communications.

[9]  M. Kiriakidou,et al.  Detection of microRNAs and assays to monitor microRNA activities in vivo and in vitro. , 2005, Methods in molecular biology.

[10]  Sam Griffiths-Jones,et al.  miRBase: the microRNA sequence database. , 2006, Methods in molecular biology.

[11]  T. Shepherd,et al.  Progress toward the discovery and development of efficacious BACE inhibitors. , 2006, Current opinion in drug discovery & development.

[12]  M. Sastre,et al.  Transcriptional and translational regulation of BACE1 expression—Implications for Alzheimer's disease , 2006, Progress in Neurobiology.

[13]  Donald C. Chang,et al.  The microRNA: overview of the RNA gene that modulates gene functions. , 2006, Methods in molecular biology.

[14]  S. Ying,et al.  Current perspectives in intronic micro RNAs (miRNAs). , 2006, Journal of biomedical science.

[15]  Jason H. Moore,et al.  Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. , 2007, Cancer research.

[16]  S. Ying,et al.  Intronic microRNAs. , 2005, Biochemical and biophysical research communications.

[17]  L. Lim,et al.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.

[18]  J. Keller,et al.  RNA in Brain Disease: No Longer Just "The Messenger in the Middle" , 2007, Journal of neuropathology and experimental neurology.

[19]  Peter T Nelson,et al.  Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. , 2007, Molecular genetics and metabolism.

[20]  R. Schliebs,et al.  Expression of β-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathology , 2000, Neuroscience Letters.

[21]  Y. Li,et al.  The FASEB Journal • Research Communication Control of APP processing and A � generation level by , 2022 .

[22]  Kenneth S. Kosik,et al.  The Elegance of the MicroRNAs: A Neuronal Perspective , 2005, Neuron.

[23]  J. Trojanowski,et al.  Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques , 1997, Annals of neurology.

[24]  Sunit K. Singh.  miRNAs: from neurogeneration to neurodegeneration. , 2007, Pharmacogenomics.

[25]  George A. Calin,et al.  Mammalian microRNAs: a small world for fine-tuning gene expression , 2006, Mammalian Genome.

[26]  M. Hentze,et al.  Complex translational regulation of BACE1 involves upstream AUGs and stimulatory elements within the 5′ untranslated region , 2007, Nucleic acids research.

[27]  W. Markesbery,et al.  Decreased RNA, and Increased RNA Oxidation, in Ribosomes from Early Alzheimer’s Disease , 2006, Neurochemical Research.

[28]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[29]  Ravi Jain,et al.  MicroRNA-143 Regulates Adipocyte Differentiation* , 2004, Journal of Biological Chemistry.

[30]  Joel S Parker,et al.  microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder , 2007, Genome Biology.

[31]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[32]  Pasko Rakic,et al.  Microarray analysis of microRNA expression in the developing mammalian brain , 2004, Genome Biology.

[33]  M. Hüll,et al.  Disease-modifying therapies in Alzheimer's disease: how far have we come? , 2006, Drugs.

[34]  E. Olson,et al.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure , 2006, Proceedings of the National Academy of Sciences.

[35]  S. Graham,et al.  Protease inhibitors as potential disease-modifying therapeutics for Alzheimer’s disease , 2005, Expert opinion on investigational drugs.

[36]  Bryan Maloney,et al.  BACE1 gene promoter is differentially regulated , 2007, Journal of Molecular Neuroscience.

[37]  D. Bartel,et al.  Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. , 2005, RNA.

[38]  N. Cairns,et al.  Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease. , 2003, Brain research. Molecular brain research.

[39]  A. Hatzigeorgiou,et al.  A combined computational-experimental approach predicts human microRNA targets. , 2004, Genes & development.

[40]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[41]  N. Bonini,et al.  MicroRNA pathways modulate polyglutamine-induced neurodegeneration. , 2006, Molecular cell.

[42]  C. Rock,et al.  Coenzyme A: back in action. , 2005, Progress in lipid research.

[43]  Xiongwei Zhu,et al.  Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron* , 2005, Journal of Biological Chemistry.

[44]  Quaid Morris,et al.  Probing microRNAs with microarrays: tissue specificity and functional inference. , 2004, RNA.

[45]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[46]  Zissimos Mourelatos,et al.  An mRNA m 7 G Cap Binding-like Motif withinHumanAgo2RepressesTranslation , 2007 .

[47]  J. Stockley,et al.  The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain. , 2007, Biochemical Society transactions.

[48]  B. Hyman,et al.  Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. , 2002, Archives of neurology.

[49]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[50]  B. de Strooper,et al.  BACE1 and Presenilin: Two Unusual Aspartyl Proteases Involved in Alzheimer’s Disease , 2004, Neurodegenerative Diseases.

[51]  W. Lukiw,et al.  Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus , 2007, Neuroreport.

[52]  M. Ohno.  Genetic and Pharmacological Basis for Therapeutic Inhibition of Band γ-Secretases in Mouse Models of Alzheimer's Memory Deficits , 2006, Reviews in the neurosciences.

[53]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[54]  G. Hannon,et al.  A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons , 2007, Science.

[55]  Karl T Kelsey,et al.  MicroRNA responses to cellular stress. , 2006, Cancer research.

[56]  T. Guo,et al.  Development of BACE1 inhibitors for Alzheimer's disease. , 2006, Current medicinal chemistry.

[57]  R. Tanzi,et al.  Depletion of GGA3 Stabilizes BACE and Enhances β-Secretase Activity , 2007, Neuron.

[58]  N. Bonini,et al.  A New Role for MicroRNA Pathways: Modulation of Degeneration Induced by Pathogenic Human Disease Proteins , 2006, Cell cycle.

[59]  W. Lukiw,et al.  Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. , 2007, Journal of inorganic biochemistry.

[60]  George A. Calin,et al.  A MicroRNA Signature of Hypoxia , 2006, Molecular and Cellular Biology.

[61]  R. Plasterk,et al.  RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. , 2005, RNA.

[62]  Zissimos Mourelatos,et al.  The microRNA world: small is mighty. , 2003, Trends in biochemical sciences.

[63]  A. G. Tahiliani,et al.  Pantothenic acid in health and disease. , 1991, Vitamins and hormones.

[64]  V. John.  Human beta-secretase (BACE) and BACE inhibitors: progress report. , 2006, Current topics in medicinal chemistry.

[65]  V. Katta,et al.  Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties. , 2000 .

[66]  R. Heinrikson,et al.  Human beta-secretase (BACE) and BACE inhibitors. , 2003, Journal of medicinal chemistry.

[67]  Y. Stern,et al.  APOE related alterations in cerebral activation even at college age , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[68]  Mark M. Davis,et al.  miR-181a Is an Intrinsic Modulator of T Cell Sensitivity and Selection , 2007, Cell.

[69]  Peter T Nelson,et al.  Clinicopathologic Correlations in a Large Alzheimer Disease Center Autopsy Cohort: Neuritic Plaques and Neurofibrillary Tangles "Do Count" When Staging Disease Severity , 2007, Journal of neuropathology and experimental neurology.

[70]  Xiaowei Wang,et al.  Systematic identification of microRNA functions by combining target prediction and expression profiling , 2006, Nucleic acids research.

[71]  M. Kiriakidou,et al.  An mRNA m7G Cap Binding-like Motif within Human Ago2 Represses Translation , 2007, Cell.

[72]  M. Mann,et al.  miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. , 2002, Genes & development.

[73]  Yvonne Tay,et al.  A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding Heteroduplexes , 2006, Cell.